Shengnan Cao
-
- Acupuncture Treatment Research Studies 4
-
- Musculoskeletal pain and rehabilitation 3
-
- Spine and Intervertebral Disc Pathology 3
- Spinal Cord Injury Research 3
-
- CRISPR and Genetic Engineering 4
- Epigenetics and DNA Methylation 3
- Fungal and yeast genetics research 3
-
- Mycorrhizal Fungi and Plant Interactions 3
- Co-authors
- Jeffrey LisseKarin N. WestlundBruce A. BaethgeRubaiyat AlamTerry A. McNearneySongcheng YuYongjun WuYuanzhen Chen
- Journals
- Journal of Biological Chemistry (1 paper)Clinical Cancer Research (1 paper)International Journal of Molecular Sciences (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Shengnan Cao
29 papers receiving 459 citations
Peers
Comparison fields: 5 of 94
- Complementary and alternative medicine 49
- Pharmacology 76
- Pathology and Forensic Medicine 60
- Rheumatology 48
- Molecular Biology 206
Countries citing papers authored by Shengnan Cao
This map shows the geographic impact of Shengnan Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengnan Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengnan Cao more than expected).
Fields of papers citing papers by Shengnan Cao
This network shows the impact of papers produced by Shengnan Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengnan Cao. The network helps show where Shengnan Cao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shengnan Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 20 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 27 | |
| 8 | 2023 | 2 | |
| 9 | 2022 | 28 | |
| 10 | 2022 | 1 | |
| 11 | 2022 | 7 | |
| 12 | 2022 | 57 | |
| 13 | 2021 | 22 | |
| 14 | 2021 | 7 | |
| 15 | 2020 | 19 | |
| 16 | 2020 | 9 | |
| 17 | 2020 | 5 | |
| 18 | 2020 | 30 | |
| 19 | 2020 | 14 | |
| 20 | 2004 | 81 |
About Shengnan Cao
Shengnan Cao is a scholar working on Aging, Complementary and alternative medicine and Complementary and Manual Therapy, having authored 32 papers that have together received 464 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (4 papers), Acupuncture Treatment Research Studies (4 papers), Musculoskeletal pain and rehabilitation (3 papers), Spine and Intervertebral Disc Pathology (3 papers), Epigenetics and DNA Methylation (3 papers), Spinal Cord Injury Research (3 papers), Mycorrhizal Fungi and Plant Interactions (3 papers) and Fungal and yeast genetics research (3 papers). The work is most often cited by research in Complementary and alternative medicine (49 citations), Pharmacology (76 citations) and Pathology and Forensic Medicine (60 citations). Shengnan Cao has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Jeffrey Lisse, Karin N. Westlund, Bruce A. Baethge, Rubaiyat Alam, Terry A. McNearney, Songcheng Yu, Yongjun Wu, Yuanzhen Chen, Bo Zhang and Mingzhe Zhang. Their work appears in journals such as Journal of Biological Chemistry, Clinical Cancer Research and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.